CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 140 filers reported holding CHINA BIOLOGIC PRODS INC in Q4 2016. The put-call ratio across all filers is 1.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $333,000 | -13.7% | 3,100 | 0.0% | 0.02% | -12.0% |
| Q3 2016 | $386,000 | +17.0% | 3,100 | 0.0% | 0.02% | +13.6% |
| Q2 2016 | $330,000 | -7.0% | 3,100 | 0.0% | 0.02% | -12.0% |
| Q1 2016 | $355,000 | -19.7% | 3,100 | 0.0% | 0.02% | -30.6% |
| Q4 2015 | $442,000 | +59.0% | 3,100 | 0.0% | 0.04% | +56.5% |
| Q3 2015 | $278,000 | -22.1% | 3,100 | 0.0% | 0.02% | -11.5% |
| Q2 2015 | $357,000 | +20.6% | 3,100 | 0.0% | 0.03% | +18.2% |
| Q1 2015 | $296,000 | +42.3% | 3,100 | 0.0% | 0.02% | +37.5% |
| Q4 2014 | $208,000 | – | 3,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WARBURG PINCUS LLC | 8,344,200 | $960,918,000 | 7.67% |
| RUDMAN ERROL M | 130,201 | $14,994,000 | 5.06% |
| Ativo Capital Management LLC | 59,101 | $7,258,000 | 2.56% |
| Kylin Management | 188,226 | $21,676,000 | 2.36% |
| Monashee Investment Management LLC | 40,000 | $4,606,000 | 2.17% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 62,866 | $7,240,000 | 1.91% |
| Cormorant Asset Management, LP | 111,500 | $12,840,000 | 1.71% |
| OBERWEIS ASSET MANAGEMENT INC/ | 53,500 | $6,161,000 | 1.63% |
| Perceptive Advisors | 147,604 | $16,998,000 | 1.02% |
| Granite Point Capital Management, L.P. | 29,160 | $3,358,000 | 0.98% |